ASCO: Longer Tx Lengthens Life in GIST (CME/CE)

CHICAGO (MedPage Today) — Extending adjuvant imatinib (Gleevec) treatment for high-risk gastrointestinal stromal tumors (GIST) substantially boosts survival, researchers found.

Post a Comment

Comments are closed.